Published in J Cardiovasc Pharmacol on September 01, 2012
Mitochondria and endothelial function. Circ Res (2013) 1.27
Molecular mechanisms of autophagy in the cardiovascular system. Circ Res (2015) 1.10
The role of ubiquitin ligases in cardiac disease. J Mol Cell Cardiol (2013) 0.88
Macrophage migration inhibitory factor (MIF) knockout preserves cardiac homeostasis through alleviating Akt-mediated myocardial autophagy suppression in high-fat diet-induced obesity. Int J Obes (Lond) (2014) 0.84
Carboxyl terminus of Hsp70-interacting protein (CHIP) is required to modulate cardiac hypertrophy and attenuate autophagy during exercise. Cell Biochem Funct (2013) 0.83
Therapeutic targeting of autophagy in cardiovascular disease. J Mol Cell Cardiol (2015) 0.79
Phellinus linteus Mycelium Alleviates Myocardial Ischemia-Reperfusion Injury through Autophagic Regulation. Front Pharmacol (2017) 0.78
The role of autophagy in cardiac hypertrophy. Acta Biochim Biophys Sin (Shanghai) (2016) 0.78
Chronic heart failure: Ca(2+), catabolism, and catastrophic cell death. Biochim Biophys Acta (2016) 0.77
Exercise capacity, physical activity, and morbidity. Heart Fail Rev (2017) 0.75
The role of autophagy during the early neonatal starvation period. Nature (2004) 22.40
Impairment of starvation-induced and constitutive autophagy in Atg7-deficient mice. J Cell Biol (2005) 18.60
Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study. N Engl J Med (1990) 17.52
Myocardial reperfusion injury. N Engl J Med (2007) 13.41
Eaten alive: a history of macroautophagy. Nat Cell Biol (2010) 8.83
The role of autophagy in cardiomyocytes in the basal state and in response to hemodynamic stress. Nat Med (2007) 8.82
Distinct roles of autophagy in the heart during ischemia and reperfusion: roles of AMP-activated protein kinase and Beclin 1 in mediating autophagy. Circ Res (2007) 8.44
Mitochondrial autophagy is an HIF-1-dependent adaptive metabolic response to hypoxia. J Biol Chem (2008) 7.71
The progression from hypertension to congestive heart failure. JAMA (1996) 7.56
Cardiac plasticity. N Engl J Med (2008) 6.29
Cardiac autophagy is a maladaptive response to hemodynamic stress. J Clin Invest (2007) 5.17
Enhancing macroautophagy protects against ischemia/reperfusion injury in cardiac myocytes. J Biol Chem (2006) 4.57
Hypertrophy of the heart: a new therapeutic target? Circulation (2004) 4.45
Response to myocardial ischemia/reperfusion injury involves Bnip3 and autophagy. Cell Death Differ (2006) 4.29
Reduction of cardiovascular risk by regression of electrocardiographic markers of left ventricular hypertrophy by the angiotensin-converting enzyme inhibitor ramipril. Circulation (2001) 3.96
Cardiac hypertrophy is not a required compensatory response to short-term pressure overload. Circulation (2000) 3.82
Regression of electrocardiographic left ventricular hypertrophy during antihypertensive treatment and the prediction of major cardiovascular events. JAMA (2004) 3.68
Hdac2 regulates the cardiac hypertrophic response by modulating Gsk3 beta activity. Nat Med (2007) 3.61
Mitochondrial ROS-induced ROS release: an update and review. Biochim Biophys Acta (2006) 3.57
Autophagy in chronically ischemic myocardium. Proc Natl Acad Sci U S A (2005) 3.55
Aggregate-prone proteins are cleared from the cytosol by autophagy: therapeutic implications. Curr Top Dev Biol (2006) 3.02
Histone deacetylase (HDAC) inhibitors attenuate cardiac hypertrophy by suppressing autophagy. Proc Natl Acad Sci U S A (2011) 2.80
Suppression of class I and II histone deacetylases blunts pressure-overload cardiac hypertrophy. Circulation (2006) 2.70
Myosin heavy chain gene expression in human heart failure. J Clin Invest (1997) 2.39
Phenotyping hypertrophy: eschew obfuscation. Circ Res (2003) 2.32
Inhibition of ischemic cardiomyocyte apoptosis through targeted ablation of Bnip3 restrains postinfarction remodeling in mice. J Clin Invest (2007) 2.23
Intracellular protein aggregation is a proximal trigger of cardiomyocyte autophagy. Circulation (2008) 1.95
Impaired autophagosome clearance contributes to cardiomyocyte death in ischemia/reperfusion injury. Circulation (2012) 1.91
Autophagy in load-induced heart disease. Circ Res (2008) 1.89
Urocortin inhibits Beclin1-mediated autophagic cell death in cardiac myocytes exposed to ischaemia/reperfusion injury. J Mol Cell Cardiol (2006) 1.83
Lysosomal alterations in hypoxic and reoxygenated hearts. I. Ultrastructural and cytochemical changes. Am J Pathol (1980) 1.75
Autophagy as a therapeutic target in cardiovascular disease. J Mol Cell Cardiol (2011) 1.48
Guidelines for the use and interpretation of assays for monitoring autophagy in higher eukaryotes. Autophagy (2007) 20.92
Guidelines for the use and interpretation of assays for monitoring autophagy. Autophagy (2012) 20.08
Dysregulation of microRNAs after myocardial infarction reveals a role of miR-29 in cardiac fibrosis. Proc Natl Acad Sci U S A (2008) 9.86
Transient regenerative potential of the neonatal mouse heart. Science (2011) 9.02
The endothelial-specific microRNA miR-126 governs vascular integrity and angiogenesis. Dev Cell (2008) 7.26
FGF23 induces left ventricular hypertrophy. J Clin Invest (2011) 7.22
Class II histone deacetylases act as signal-responsive repressors of cardiac hypertrophy. Cell (2002) 7.10
Heart repair by reprogramming non-myocytes with cardiac transcription factors. Nature (2012) 6.65
Cardiac autophagy is a maladaptive response to hemodynamic stress. J Clin Invest (2007) 5.17
Exercise-induced BCL2-regulated autophagy is required for muscle glucose homeostasis. Nature (2012) 4.84
Histone deacetylases 1 and 2 redundantly regulate cardiac morphogenesis, growth, and contractility. Genes Dev (2007) 4.50
Hypertrophy of the heart: a new therapeutic target? Circulation (2004) 4.45
Histone deacetylases 5 and 9 govern responsiveness of the heart to a subset of stress signals and play redundant roles in heart development. Mol Cell Biol (2004) 4.24
Fibrosis--a common pathway to organ injury and failure. N Engl J Med (2015) 3.94
Mitochondrial deficiency and cardiac sudden death in mice lacking the MEF2A transcription factor. Nat Med (2002) 3.31
Activated glycogen synthase-3 beta suppresses cardiac hypertrophy in vivo. Proc Natl Acad Sci U S A (2002) 3.27
Reprogramming of human fibroblasts toward a cardiac fate. Proc Natl Acad Sci U S A (2013) 3.14
Stress-dependent cardiac remodeling occurs in the absence of microRNA-21 in mice. J Clin Invest (2010) 3.04
Histone deacetylase (HDAC) inhibitors attenuate cardiac hypertrophy by suppressing autophagy. Proc Natl Acad Sci U S A (2011) 2.80
TRPC6 fulfills a calcineurin signaling circuit during pathologic cardiac remodeling. J Clin Invest (2006) 2.74
Suppression of class I and II histone deacetylases blunts pressure-overload cardiac hypertrophy. Circulation (2006) 2.70
The delta isoform of CaM kinase II is required for pathological cardiac hypertrophy and remodeling after pressure overload. Proc Natl Acad Sci U S A (2009) 2.66
Foxo transcription factors blunt cardiac hypertrophy by inhibiting calcineurin signaling. Circulation (2006) 2.55
Pathogenesis of myocardial ischemia-reperfusion injury and rationale for therapy. Am J Cardiol (2010) 2.52
The transcriptional coactivator CAMTA2 stimulates cardiac growth by opposing class II histone deacetylases. Cell (2006) 2.26
The MEF2D transcription factor mediates stress-dependent cardiac remodeling in mice. J Clin Invest (2008) 2.24
A dynamic notch injury response activates epicardium and contributes to fibrosis repair. Circ Res (2010) 2.23
Requirement of protein kinase D1 for pathological cardiac remodeling. Proc Natl Acad Sci U S A (2008) 2.12
Mice lacking calsarcin-1 are sensitized to calcineurin signaling and show accelerated cardiomyopathy in response to pathological biomechanical stress. Nat Med (2004) 2.11
FoxO transcription factors activate Akt and attenuate insulin signaling in heart by inhibiting protein phosphatases. Proc Natl Acad Sci U S A (2007) 2.08
Histone deacetylase inhibition blunts ischemia/reperfusion injury by inducing cardiomyocyte autophagy. Circulation (2014) 2.07
Autophagy is an adaptive response in desmin-related cardiomyopathy. Proc Natl Acad Sci U S A (2008) 2.07
Abnormal coronary function in mice deficient in alpha1H T-type Ca2+ channels. Science (2003) 2.05
Intracellular protein aggregation is a proximal trigger of cardiomyocyte autophagy. Circulation (2008) 1.95
Macrophages are required for neonatal heart regeneration. J Clin Invest (2014) 1.93
Impaired autophagosome clearance contributes to cardiomyocyte death in ischemia/reperfusion injury. Circulation (2012) 1.91
MicroRNA-214 protects the mouse heart from ischemic injury by controlling Ca²⁺ overload and cell death. J Clin Invest (2012) 1.90
Autophagy in load-induced heart disease. Circ Res (2008) 1.89
Increased ER-mitochondrial coupling promotes mitochondrial respiration and bioenergetics during early phases of ER stress. J Cell Sci (2011) 1.65
Metabolic stress-induced activation of FoxO1 triggers diabetic cardiomyopathy in mice. J Clin Invest (2012) 1.63
Modulation of adverse cardiac remodeling by STARS, a mediator of MEF2 signaling and SRF activity. J Clin Invest (2007) 1.50
Does load-induced ventricular hypertrophy progress to systolic heart failure? Am J Physiol Heart Circ Physiol (2005) 1.50
Autophagy as a therapeutic target in cardiovascular disease. J Mol Cell Cardiol (2011) 1.48
Pathological ventricular remodeling: mechanisms: part 1 of 2. Circulation (2013) 1.48
C/EBP transcription factors mediate epicardial activation during heart development and injury. Science (2012) 1.48
Endometriosis and subfertility: is the relationship resolved? Semin Reprod Med (2003) 1.48
Calcineurin is necessary for the maintenance but not embryonic development of slow muscle fibers. Mol Cell Biol (2005) 1.47
Physical and functional interaction between calcineurin and the cardiac L-type Ca2+ channel. Circ Res (2009) 1.42
Enhanced autophagy ameliorates cardiac proteinopathy. J Clin Invest (2013) 1.41
Cardiovascular side effects of cancer therapies: a position statement from the Heart Failure Association of the European Society of Cardiology. Eur J Heart Fail (2011) 1.40
Differential activation of stress-response signaling in load-induced cardiac hypertrophy and failure. Physiol Genomics (2005) 1.39
Cardiac myosin light chain kinase is necessary for myosin regulatory light chain phosphorylation and cardiac performance in vivo. J Biol Chem (2010) 1.37
Diabetic Cardiomyopathy: Mechanisms and Therapeutic Targets. Drug Discov Today Dis Mech (2010) 1.28
The Xbp1s/GalE axis links ER stress to postprandial hepatic metabolism. J Clin Invest (2012) 1.23
Endoplasmic reticulum and the unfolded protein response: dynamics and metabolic integration. Int Rev Cell Mol Biol (2013) 1.23
STIM1-dependent store-operated Ca²⁺ entry is required for pathological cardiac hypertrophy. J Mol Cell Cardiol (2011) 1.18
Ca2+/calmodulin-dependent protein kinase II-dependent remodeling of Ca2+ current in pressure overload heart failure. J Biol Chem (2008) 1.16
Autophagy in hypertensive heart disease. J Biol Chem (2010) 1.15
Autophagy in cardiovascular biology. J Clin Invest (2015) 1.14
The histone trimethyllysine demethylase JMJD2A promotes cardiac hypertrophy in response to hypertrophic stimuli in mice. J Clin Invest (2011) 1.13
FoxO, autophagy, and cardiac remodeling. J Cardiovasc Transl Res (2010) 1.11
Myocyte autophagy in heart disease: friend or foe? Autophagy (2007) 1.09
Electrophysiological remodeling in heart failure. J Mol Cell Cardiol (2010) 1.05
Adipose tissue biology and cardiomyopathy: translational implications. Circ Res (2012) 1.05
Tuning flux: autophagy as a target of heart disease therapy. Curr Opin Cardiol (2011) 1.05
Histone deacetylase inhibition in the treatment of heart disease. Expert Opin Drug Saf (2008) 1.04
Doxycycline attenuates isoproterenol- and transverse aortic banding-induced cardiac hypertrophy in mice. J Pharmacol Exp Ther (2007) 1.04
Energy-preserving effects of IGF-1 antagonize starvation-induced cardiac autophagy. Cardiovasc Res (2011) 1.03
Reversibility of adverse, calcineurin-dependent cardiac remodeling. Circ Res (2011) 1.03
Insulin stimulates mitochondrial fusion and function in cardiomyocytes via the Akt-mTOR-NFκB-Opa-1 signaling pathway. Diabetes (2013) 1.01
Cx30.2 enhancer analysis identifies Gata4 as a novel regulator of atrioventricular delay. Development (2009) 1.01
Diabetic cardiomyopathy and metabolic remodeling of the heart. Life Sci (2012) 1.00
HDAC-dependent ventricular remodeling. Trends Cardiovasc Med (2013) 1.00
FHL2 binds calcineurin and represses pathological cardiac growth. Mol Cell Biol (2012) 1.00
The CCAAT/enhancer binding protein beta (C/EBPbeta) cooperates with NFAT to control expression of the calcineurin regulatory protein RCAN1-4. J Biol Chem (2010) 1.00
Remodeling of early-phase repolarization: a mechanism of abnormal impulse conduction in heart failure. Circulation (2006) 0.99
Dual control of cardiac Na+ Ca2+ exchange by PIP(2): analysis of the surface membrane fraction by extracellular cysteine PEGylation. J Physiol (2007) 0.97
COCATS 4 Task Force 15: Training in Cardiovascular Research and Scholarly Activity. J Am Coll Cardiol (2015) 0.97
Transient-outward K+ channel inhibition facilitates L-type Ca2+ current in heart. J Cardiovasc Electrophysiol (2006) 0.97
New autophagy reporter mice reveal dynamics of proximal tubular autophagy. J Am Soc Nephrol (2013) 0.95
Remodeling of outward K+ currents in pressure-overload heart failure. J Cardiovasc Electrophysiol (2007) 0.95
Guidelines for translational research in heart failure. J Cardiovasc Transl Res (2015) 0.95
Cardiomyocyte autophagy: remodeling, repairing, and reconstructing the heart. Curr Hypertens Rep (2009) 0.95
Mechanical unloading activates FoxO3 to trigger Bnip3-dependent cardiomyocyte atrophy. J Am Heart Assoc (2013) 0.94
Targeting of protein phosphatases PP2A and PP2B to the C-terminus of the L-type calcium channel Ca v1.2. Biochemistry (2010) 0.93
Diminished cardiac fibrosis in heart failure is associated with altered ventricular arrhythmia phenotype. J Cardiovasc Electrophysiol (2010) 0.92
Detection of implantation-related cytokines in cervicovaginal secretions and peripheral blood of fertile women during ovulatory menstrual cycles. Fertil Steril (2004) 0.92
Myocyte enhancer factor 2 and class II histone deacetylases control a gender-specific pathway of cardioprotection mediated by the estrogen receptor. Circ Res (2009) 0.90
Fibrosis--A Common Pathway to Organ Injury and Failure. N Engl J Med (2015) 0.90
Pathological ventricular remodeling: therapies: part 2 of 2. Circulation (2013) 0.90
The complex interplay between mitochondrial dynamics and cardiac metabolism. J Bioenerg Biomembr (2011) 0.89
Sustained hemodynamic stress disrupts normal circadian rhythms in calcineurin-dependent signaling and protein phosphorylation in the heart. Circ Res (2011) 0.89
Hic-5 is required for fetal gene expression and cytoskeletal organization of neonatal cardiac myocytes. J Mol Cell Cardiol (2009) 0.89
Reactive oxygen species suppress cardiac NaV1.5 expression through Foxo1. PLoS One (2012) 0.89
Second statement of the working group on electrocardiographic diagnosis of left ventricular hypertrophy. J Electrocardiol (2011) 0.88
Forkhead factor FoxO1 is essential for placental morphogenesis in the developing embryo. Proc Natl Acad Sci U S A (2011) 0.88
Mitochondrial fission and autophagy in the normal and diseased heart. Curr Hypertens Rep (2010) 0.88
The heart of autophagy: deconstructing cardiac proteotoxicity. Autophagy (2008) 0.87
Oxidative stress and autophagy in cardiovascular homeostasis. Antioxid Redox Signal (2013) 0.86
Regulation of atrial natriuretic peptide secretion by a novel Ras-like protein. J Cell Biol (2007) 0.85